Chemotherapy News and Research

Latest Chemotherapy News and Research

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.

17 May 2004

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists at Temple University Hospital now are able to treat many patients with minimally invasive procedures not available only a few years ago. “Conditions that used to require extensive surgery now take an hour or less, and patients leave with a bandaid and walk home,” says Gary Cohen, M.D., Section Chief of Interventional Radiology and Vice Chairman of Radiology. “How can you beat that?”

17 May 2004

Genetically engineered viruses may create new class of cancer therapies

A genetically engineered virus can selectively kill cancerous cells in the lung and colon while leaving healthy cells intact, according to new research published today in Cancer Research by William Wold and colleagues at Saint Louis University School of Medicine.

15 May 2004

Vitamin discovery offers clues for cancer chemotherapy

NH-Dartmouth Medical School cancer researchers, in a fusion of biochemistry and genetics, have discovered a new vitamin in a molecular pathway central to such vital processes as gene regulation, metabolism and aging. And, they found that milk contains this nutrient.

15 May 2004

Chromosome losses can signal an especially poor response to therapy

A new international study of children with a severe form of acute lymphoblastic leukemia(ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.

13 May 2004

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.

12 May 2004

Restrictions by health insurers and government to control expenses may hurt the malignant melanoma drug market

Decision Resources, Inc., a research and advisory firms focusing on pharmaceutical and health care issues, finds that restrictions by health insurers and government health authorities to control expenses may hurt the malignant melanoma drug market.

12 May 2004

Nanobodies herald a new era in cancer therapy

Cancer, along with heart and vascular disease, is the major cause of death in the Western world. The first generation of anti-cancer drugs has already saved many lives, but because these medicines are non-specific they also often have severe side effects.

12 May 2004

Alternative vaccine to Dryvax for smallpox

Not everybody can safely be vaccinated against smallpox using the current FDA-approved vaccine. Scientists hope another study vaccine, now undergoing its first testing in the United States at Saint Louis University, will give a choice to people who can't be given the current vaccine, known as Dryvax®.

10 May 2004

West Nile treatment showing 100% response rate among immunocompetent patients

GenoMed, Inc. has announced that it will be limiting its treatment for West Nile virus encephalitis to immunocompetent patients only, where it has posted a 100% success rate.

7 May 2004

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.

5 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004

African American and Asian American patients are less likely than whites to turn to a medical specialist

African American and Asian American patients are less likely than whites to turn to a medical specialist for their initial care, suggesting a possible explanation for why racial differences in health care exist, according to a new UCLA study.

4 May 2004

Discovery of molecular switch could lead to new treatments for lymphoma and other forms of cancer

Turning a vital component of cancer cells from bodyguard to assassin could form the basis of new cancer treatments, according to a report published this week.

4 May 2004

Radiologists use CT-Scans to inject gene therapy into tumors

Using CT-scan images to steer gene-therapy injections directly into the tumor offers a safe delivery method for treating patients with metastatic kidney cancer, report UCLA radiologists in the May issue of Radiology. Their findings could enhance the treatment of the disease, which resists traditional intravenous chemotherapy in 85 percent of cases.

4 May 2004

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

Pharmaceutical science leaders from the FDA, research institutions and top pharmaceutical companies will gather at the 2004 AAPS National Biotechnology Conference, AAPS' spring annual meeting.

4 May 2004

South Asian breast cancer patients may have higher rates of mastectomy compared with non-Asians

South Asian breast cancer patients living in Yorkshire may have higher rates of mastectomy compared with non-Asians because they present to their GPs too late, Cancer Research UK scientists reveal today

4 May 2004

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Progen Industries Limited, an Australian anti-cancer drug development company, announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for their lead anti-angiogenesis product PI-88 for treatment of malignant melanoma.

3 May 2004

Study shows those with weak immune systems should avoid the shower

A study out of the San Diego State University Center for Microbial Sciences reveals that hundreds of millions of colorful bacteria thrive on shower curtains, waiting to attack those who think they are getting clean.

3 May 2004

Chemical thumbprint can help determine if tumor is returning or dying

Brain tumor survivors live with the constant worry that their cancer might come back. And even if they have a brain scan every few months to check, doctors often can't tell the difference between new cancer growth and tissue changes related to their treatment with radiation or chemotherapy.

3 May 2004

Chemotherapy News and Research

Latest Chemotherapy News and Research

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

Interventional radiologists now are able to treat using minimally invasive procedures

Genetically engineered viruses may create new class of cancer therapies

Vitamin discovery offers clues for cancer chemotherapy

Chromosome losses can signal an especially poor response to therapy

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Restrictions by health insurers and government to control expenses may hurt the malignant melanoma drug market

Nanobodies herald a new era in cancer therapy

Alternative vaccine to Dryvax for smallpox

West Nile treatment showing 100% response rate among immunocompetent patients

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

World's first gene therapy trial aimed at preventing cancer

African American and Asian American patients are less likely than whites to turn to a medical specialist

Discovery of molecular switch could lead to new treatments for lymphoma and other forms of cancer

Radiologists use CT-Scans to inject gene therapy into tumors

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

South Asian breast cancer patients may have higher rates of mastectomy compared with non-Asians

Australian company receives FDA orphan drug designation for product to treat malignant melanomas

Study shows those with weak immune systems should avoid the shower

Chemical thumbprint can help determine if tumor is returning or dying

Cancer Research eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in